New Zealand's only large-scale beef feedlot has confirmed a Mycoplasma bovis infection.
The event recognised the successes of New Zealand companies developing, manufacturing and exporting natural products, functional foods, complementary medicines, ‘cosmeceuticals’ and ‘nutraceuticals’ industries.
The supreme award acknowledged Quantec as the best overall entrant in the four awards categories open at this year’s event.
Quantec chief executive Dr Rod Claycomb says it’s great to be recognised.
“We’ve experienced sustainable growth over the past nine years – a factor I imagine played a part in us receiving this award.
“We’re a small business with science at our heart, yet we’re experiencing commercial success here in New Zealand and in several key markets overseas.
“We’re a relatively young company: we started our natural dairy-based ingredient activities in 2009. It’s been a challenging road to get to this point and heartening to be recognised by the industry for our successes along the way,” says Claycomb.
Quantec also won the Fernmark License programme growth award and was recognised as highly commended in the Cawthrown Innovation Award category.
Quantec manufactures a patented dairy ingredient -- IDP -- which is used by its customers to make products such as dietary health supplements and skincare. Its largest market for the ingredient is China.
Quantec also manufactures anti-acne products under the Epiology brand which contain IDP. Epiology is distributed through NZ pharmacies and Mexico is the company’s largest export market for the anti-acne skincare range.
The company set up a company in China in February this year, hiring staff and planning to expand.
Quantec is a past finalist in the NZ Innovator of the Year Awards and has won a Kudos Hamilton Science Award.